Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Neoleukin Therapeutics, Inc.
4 Apr 23
4
Neoleukin Therapeutics, Inc.
3 Feb 23
4
Neoleukin Therapeutics, Inc.
4 Aug 22
4
Neoleukin Therapeutics, Inc.
3 May 22
4
Neoleukin Therapeutics, Inc.
2 Feb 22
4
Neoleukin Therapeutics, Inc.
5 Aug 21
4
Neoleukin Therapeutics, Inc.
4 May 21
3
Neoleukin Therapeutics, Inc.
4 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Apr 23 | NGNE Neurogene | Common Stock | Sell | Dispose S | No | No | 0.6919 | 3,769 | 2.61 k | 37,313 |
31 Mar 23 | NGNE Neurogene | Common Stock | Option exercise | Acquire M | No | No | 0 | 10,000 | 0.00 | 41,082 |
31 Mar 23 | NGNE Neurogene | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 10,000 | 0.00 | 0 |
2 Feb 23 | NGNE Neurogene | Common Stock | Sell | Dispose S | No | No | 0.5972 | 14,380 | 8.59 k | 31,082 |
1 Feb 23 | NGNE Neurogene | Common Stock | Option exercise | Acquire M | No | No | 0 | 35,000 | 0.00 | 45,462 |
1 Feb 23 | NGNE Neurogene | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 35,000 | 0.00 | 35,000 |